FDA Interoperability Designation—Creating Options for People With Diabetes and Pump Companies: Regulatory,Technological,and Commercial Perspectives

Abstract

Keywords

AID system algorithm alternate controller enabled pump diabetes technology interoperable automated glycemic controller interoperable continuous glucose monitor

Get full access to this article

View all access options for this article.

References

Food and Drug Administration. FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-interoperable-automated-insulin-dosing-controller-designed-allow-more-choices. Published March 24, 2020. Accessed July 15, 2024.

Kelm

Re: SmartAdjust Technology 510(k) Premarket Notification of Intent to Market the Device. US FDA; 2022. www.accessdata.fda.gov/cdrh_docs/pdf20/K203774.pdf. Accessed July 15, 2024.

Insulet Announces FDA 510(k) Clearance of the Omnipod^® 5 App for iPhone. https://investors.insulet.com/news/news-details/2023/Insulet-Announces-FDA-510k-Clearance-of-the-Omnipod-5-App-for-iPhone/default.aspx. Accessed July 15, 2024.

Federal Register. Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Interoperable Automated Glycemic Controller. https://www.federalregister.gov/documents/2022/03/14/2022-05303/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the. Published March 14, 2022. Accessed July 15, 2024.

Food and Drug Administration. FDA Roundup: January 24, 2023.https://www.fda.gov/news-events/press-announcements/fda-roundup-january-24-2023. Published January 24, 2023. Accessed July 15, 2024.

Sequel’s twiist^TM automated insulin delivery system receives FDA 510(k) Clearance. BioSpace. https://www.biospace.com/sequel-s-twiist-automated-insulin-delivery-system-receives-fda-510-k-clearance. Published March 18, 2024. Accessed July 15, 2024.

Balsam

Re: iLet Dosing Decision Software 510(k) Premarket Notification of Intent to Market the Device. US Food and Drug Administration; 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232224.pdf. Accessed July 15, 2024.

Food and Drug Administration. FDA clears new insulin pump and algorithm-based software to support enhanced automatic insulin delivery. https://www.fda.gov/news-events/press-announcements/fda-clears-new-insulin-pump-and-algorithm-based-software-support-enhanced-automatic-insulin-delivery. Published May 22, 2023. Accessed July 15, 2024.

mylife Loop offers new remote monitoring feature for parents.https://www.ypsomed.com/en/media/details/mylife-loop-offers-new-remote-monitoring-feature-for-parents.html. Published June 7, 2023. Accessed July 15, 2024.

10.

Omnipod^® 5 automated insulin delivery system Omnipod. https://www.omnipod.com/what-is-omnipod/omnipod-5?utm_source=google&utm_medium=paid&utm_campaign=prso-aw&utm_content=pmax-brnd&ctoken=7012J000001gYaiQAE&utm_id=21364100800&ad_group_id=&gad_source=1. Accessed July 15, 2024.

11.

Whooley

SA.

Sequel Med Tech’s Unique Twiist AID System. Drug Delivery Business. https://www.drugdeliverybusiness.com/look-at-sequel-med-tech-twiist/. Published June 22, 2024. Accessed July 22, 2024.

12.

Tandem Diabetes. t:slim X2 Insulin Pump Type 1 diabetes insulin pump tandem diabetes care. https://www.tandemdiabetes.com/products/insulin-pumps/t-slim-x2-insulin-pump. Accessed July 15, 2024.

13.

Tandem secures FDA approval for t:slim X2 insulin pump with Control-IQ. NS Medical Devices. https://www.nsmedicaldevices.com/news/tandem-slim-x2-insulin-pump/.Published December 16, 2019. Accessed July 15, 2024.

14.

Tandem Diabetes Care. Tandem Diabetes Care announces FDA approval and launch of t:slim X2 insulin pump with Dexcom G5 Mobile CGM Integration. https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-fda-approval-and-launch-tslim-x2/. Accessed July 15, 2024.

15.

Tandem Diabetes Care. Tandem Diabetes Care launches Tandem Mobi, the world’s smallest, durable automated insulin delivery system. https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-launches-tandem-mobi-worlds-smallest/. Accessed July 15, 2024.

16.

US Food and Drug Administration. 510(k) substantial equivalence determination decision summary: CamDiab Ltd. https://www.accessdata.fda.gov/cdrh_docs/reviews/K232603.pdf. Accessed July 22, 2024.

17.

Food and Drug Administration. FDA Roundup: May 24, 2024. https://www.fda.gov/news-events/press-announcements/fda-roundup-may-24-2024. Published May 24, 2024. Accessed July 22, 2024.

18.

Tidepool loop clearance. https://www.tidepool.org/blog/tidepool-loop-has-received-fda-clearance. Accessed July 22, 2024.

19.

Tidepool loop traditional 510(k) premarket notification, K203689. US Food and Drug Administration; 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf20/K203689.pdf. Accessed July 22, 2024.

20.

Abbott MediaRoom. Tandem Diabetes Care’s t:slim X2^TM insulin pump is the first automated insulin delivery system to integrate with Abbott’s New FreeStyle Libre^® 2 Plus sensor. https://abbott.mediaroom.com/2024-01-08-Tandem-Diabetes-Cares-t-slim-X2-Insulin-Pump-is-the-First-Automated-Insulin-Delivery-System-to-Integrate-with-Abbotts-New-FreeStyle-Libre-2-Plus-Sensor. Accessed July 22, 2024.

21.

How accurate is my FreeStyle Libre 2 Plus sensor? FAQ.https://www.support.freestyle.abbott/hc/en-us/articles/21906401259665-How-accurate-is-my-FreeStyle-Libre-2-Plus-sensor. Accessed July 22, 2024.

22.

Abbott MediaRoom. U.S.FDA Clears Abbott’s FreeStyle Libre^® 2 and FreeStyle Libre^® 3 sensors for integration with automated insulin delivery systems. https://abbott.mediaroom.com/2023-03-06-U-S-FDA-Clears-Abbotts-FreeStyle-Libre-R-2-and-FreeStyle-Libre-R-3-Sensors-for-Integration-with-Automated-Insulin-Delivery-Systems. Accessed July 22, 2024.

23.

Business Wire, Inc. Eversense® CGM system receives iCGM designation by the US FDA. https://www.businesswire.com/news/home/20240429218967/en/. Published April 30, 2024. Accessed July 22, 2024.

24.

Dexcom G7 receives FDA clearance: The most accurate continuous glucose monitoring system cleared in the U.S. https://investors.dexcom.com/news/news-details/2022/Dexcom-G7-Receives-FDA-Clearance-The-Most-Accurate-Continuous-Glucose-Monitoring-System-Cleared-in-the-U.S/default.aspx. Accessed July 22, 2024.

25.

FDA-approved insulin pumps used for insulin pump therapy. https://lifesciencesintelligence.com/features/fda-approved-insulin-pumps-used-for-insulin-pump-therapy. Accessed July 15, 2024.

26.

Food and Drug Administration. FDA approves first automated insulin delivery device for type 1 diabetes. https://www.fda.gov/news-events/press-announcements/fda-approves-first-automated-insulin-delivery-device-type-1-diabetes. Published March 24, 2020. Accessed July 15, 2024.

27.

Food and Drug Administration. MiniMed 780G System. https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160017S091B.pdf. Accessed June 25, 2024.

28.

FAQs—MiniMed^TM 770G system support medtronic. https://www.medtronicdiabetes.com/customer-support/minimed-770G-system-faqs. Published April 29, 2021. Accessed July 15, 2024.

29.

Integrated Diabetes Services. Medtronic 770G insulin pump pros cons. https://integrateddiabetes.com/medtronic-770g-insulin-pump-pros-and-cons/. Published December 30, 2020. Accessed July 15, 2024.

30.

Caposino

Re: MiniMed 780G System Premarket Approval Application Supplement. US Food and Drug Administration; 2021. https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160017S091A.pdf. Accessed July 15, 2024.

31.

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices. Abbott. https://abbott.mediaroom.com/2024-08-07-Abbott-Enters-Global-Partnership-to-Connect-Its-World-Leading-Continuous-Glucose-Monitoring-System-with-Medtronics-Insulin-Delivery-Devices. August 7, 2024. Accessed August 26, 2024.

32.

Medtronic announces FDA approval of SimpleraTM CGM and global partnership with Abbott. Medtronic News. https://news.medtronic.com/2024-08-07-Medtronic-announces-FDA-approval-of-Simplera-TM-CGM-and-global-partnership-with-Abbott. August 7, 2024. Accessed August 26, 2024.

33.

Food and Drug Administration. Center for Devices and Radiological Health. Premarket Notification 510(k). https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k. Published December 5, 2023. Accessed July 15, 2024.

34.

Braune

Lal

Petruželková

, et al. Open-source automated insulin delivery: International consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol. 2022;10(1):58-74. doi:10.1016/S2213-8587(21)00267-9.

35.

IEEE SA. IEEE Medical Device Cybersecurity Certification Program.https://standards.ieee.org/products-programs/icap/programs/medical-devices-cybersecurity/. Accessed July 15, 2024

36.

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes. Insulet. https://investors.insulet.com/news/news-details/2024/Omnipod-5-Automated-Insulin-Delivery-System-is-now-FDA-cleared-for-People-with-Type-2-Diabetes/default.aspx. August 26, 2024. Accessed August 26, 2024.